14 results
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
incurred and expects to expend significant capital and other resources to ensure ongoing compliance with applicable privacy and data security laws
DEF 14A
PNT
POINT Biopharma Global Inc.
28 Apr 22
Definitive proxy
8:36am
programs and management’s periodic evaluation of the effectiveness of such programs;
reviewing the Company’s data security compliance programs, management’s
424B3
PNT
POINT Biopharma Global Inc.
31 Mar 22
Prospectus supplement
11:42am
to ensure ongoing compliance with applicable privacy and data security laws and to prevent security breaches, including costs related to deploying
POS AM
PNT
POINT Biopharma Global Inc.
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
incurred and expects to expend significant capital and other resources to ensure ongoing compliance with applicable privacy and data security laws
424B3
jhnjsis
5 Aug 21
Prospectus supplement
4:26pm
424B3
ufmhxjzaa077zgl
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
rotbw2w amod667u
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
8io q3i2z8
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
lndy15rjrv91une
18 Mar 21
Financial Statements and Exhibits
9:08am
- Prev
- 1
- Next